Theravance Biopharma, Inc. (TBPH)

Last Three Months

25-Aug-24 -- 24-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

34

0

0

+1

0

+2

0

+3

Two Year Chart

25-Nov-22 -- 24-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
22-Nov-24 6:10 PM View:	20-Nov-24 Payment of Exercise ($159.49K)	Winningham Rick E Chief Executive Officer Director		Theravance Biopharma, Inc. - TBPH	(1%) 1.92M to 1.91M	0	0	--	--	Show Txns Hide Txns

22-Nov-24 6:04 PM View:	20-Nov-24 Payment of Exercise ($91.50K)	Farnum Rhonda SVP, Comm & Medical Affairs		Theravance Biopharma, Inc. - TBPH	(3%) 322.74K to 313.56K	0	0	--	--	Show Txns Hide Txns

22-Nov-24 6:09 PM View:	20-Nov-24 Payment of Exercise ($84.52K)	Sawaf Aziz SVP & Chief Financial Officer		Theravance Biopharma, Inc. - TBPH	(3%) 321.37K to 312.89K	0	0	--	--	Show Txns Hide Txns

22-Nov-24 6:06 PM View:	20-Nov-24 Payment of Exercise ($92.40K)	Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY		Theravance Biopharma, Inc. - TBPH	(3%) 342.61K to 333.35K	0	0	--	--	Show Txns Hide Txns

22-Nov-24 6:08 PM View:	20-Nov-24 Payment of Exercise ($100.46K)	Miller Aine SVP, Dev & Head of IRE Office		Theravance Biopharma, Inc. - TBPH	(6%) 160.63K to 150.56K	0	0	--	--	Show Txns Hide Txns